Subtle changes in the choice of the chalcogen atom in benzochalcogenadiazole ‘small molecules’ can lead to a marked difference in the PCE of bulk heterojunction organic solar cells.
No takes yet. Share an insight, caveat, or question.
Cameron et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: